Zymeworks (ZYME) Current Assets (2021 - 2026)

Zymeworks (ZYME) has 6 years of Current Assets data on file, last reported at $385.7 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 25.85% year-over-year to $385.7 million; the trailing twelve-month figure through Mar 2026 stood at $385.7 million (up 25.85% YoY), and the FY2025 full-year result was $248.8 million, down 17.2% from the prior year.
• Current Assets rose to $385.7 million in Q1 2026, from $248.8 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $544.7 million in Q4 2022 to a low of $190.7 million in Q3 2022.
• A 5-year average of $354.7 million and a median of $374.6 million in 2023 frame the typical range for Current Assets.
• Across the five-year window, Current Assets soared 96.5% in 2023 and declined 27.24% in 2024, its largest moves.
• Tracing ZYME's Current Assets over 5 years: stood at $544.7 million in 2022, then slipped by 24.19% to $412.9 million in 2023, then fell by 27.24% to $300.5 million in 2024, then fell by 17.2% to $248.8 million in 2025, then surged by 55.04% to $385.7 million in 2026.
• Business Quant data shows ZYME's Current Assets at $385.7 million in Q1 2026, $248.8 million in Q4 2025, and $291.7 million in Q3 2025.